273 related articles for article (PubMed ID: 26919451)
41. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data.
Wood RC; Stewart DW; Slusher L; El-Bazouni H; Cluck D; Freshour J; Odle B
Pharmacotherapy; 2015 Jul; 35(7):663-9. PubMed ID: 26095331
[TBL] [Abstract][Full Text] [Related]
42. Rivaroxaban Concentration in Breast Milk During Breastfeeding: A Case Study.
Saito J; Kaneko K; Yakuwa N; Kawasaki H; Yamatani A; Murashima A
Breastfeed Med; 2019 Dec; 14(10):748-751. PubMed ID: 31746638
[No Abstract] [Full Text] [Related]
43. [Acute Carpal Tunnel Syndrome due to Spontaneous Bleeding after Taking Rivaroxaban (Xarelto®)].
Hohendorff B; Biber F; Sauer H; Franke J
Handchir Mikrochir Plast Chir; 2016 Jun; 48(3):168-70. PubMed ID: 25970598
[TBL] [Abstract][Full Text] [Related]
44. Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.
Beyer-Westendorf J; Ehlken B; Evers T
Europace; 2016 Aug; 18(8):1150-7. PubMed ID: 26830891
[TBL] [Abstract][Full Text] [Related]
45. Spontaneous, Life-Threatening Hemorrhagic Cardiac Tamponade Secondary to Rivaroxaban.
Kham NM; Song M
Am J Ther; 2016; 23(4):e1128-31. PubMed ID: 26035030
[TBL] [Abstract][Full Text] [Related]
46. Direct oral anticoagulant drugs (DOAC).
Blum RA; Lindfield D
J Cataract Refract Surg; 2016 Jan; 42(1):171-2. PubMed ID: 26948793
[No Abstract] [Full Text] [Related]
47. Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage.
Jun JH; Hwang JC
JAMA Ophthalmol; 2015 Oct; 133(10):1184-6. PubMed ID: 26111247
[TBL] [Abstract][Full Text] [Related]
48. Fighting residual cardiovascular risk in stable patients with atherosclerotic vascular disease: COMPASS in context.
Patrono C
Cardiovasc Res; 2017 Dec; 113(14):e61-e63. PubMed ID: 29186439
[No Abstract] [Full Text] [Related]
49. Superior mesenteric artery thrombosis after abrupt discontinuation of rivaroxaban.
Adams CB; Acquisto NM; Rotoli JM; LoStracco T; Shamaskin AR; Pasternack JS
Am J Emerg Med; 2016 Apr; 34(4):764.e5-7. PubMed ID: 26439093
[TBL] [Abstract][Full Text] [Related]
50. A rare cause of GI bleeding in a patient with cutaneous vascular malformations.
Tsoutsouki J; Laskaratos FM; Mason S; Smith M; Sinha L
Gut; 2016 Nov; 65(11):1792. PubMed ID: 26809732
[No Abstract] [Full Text] [Related]
51. Dosing of rivaroxaban by indication: getting the right dose for the patient.
Escolar G; Carne X; Arellano-Rodrigo E
Expert Opin Drug Metab Toxicol; 2015; 11(10):1665-77. PubMed ID: 26329812
[TBL] [Abstract][Full Text] [Related]
52. Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
Krause M; Henningsen A; Torge A; Juhl D; Junker R; Kenet G; Kowalski D; Limperger V; Mesters R; Anonymous ; Rocke A; Shneyder M; Clausnizer H; Schiesewitz H; Nowak-Göttl U
Thromb Res; 2016 Dec; 148():145-151. PubMed ID: 27687905
[No Abstract] [Full Text] [Related]
53. Which oral anticoagulant for atrial fibrillation.
Med Lett Drugs Ther; 2016 Apr; 58(1492):45-6. PubMed ID: 27049507
[No Abstract] [Full Text] [Related]
54. Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials.
Beyer-Westendorf J; Lensing AW; Arya R; Bounameaux H; Cohen AT; Wells PS; Middeldorp S; Verhamme P; Hughes R; Kucher N; Pap AF; Trajanovic M; Prins MH; Prandoni P; Weitz JI
Thromb Res; 2017 Jan; 149():29-37. PubMed ID: 27886530
[TBL] [Abstract][Full Text] [Related]
55. [Pruritus and rivaroxaban].
Aguilar-Shea AL; Gallardo-Mayo C
Semergen; 2018; 44(4):e96-e97. PubMed ID: 29439912
[No Abstract] [Full Text] [Related]
56. Spontaneous splenic rupture due to rivaroxaban.
Nagaraja V; Cranney G; Kushwaha V
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29507024
[TBL] [Abstract][Full Text] [Related]
57. [Real life clinical management of nonvalvular atrial fibrillation: results from the Italian epidemiological survey eXperience on the use of rivaroxaban].
Colonna P; Ammirati F;
G Ital Cardiol (Rome); 2016 Nov; 17(11):932-939. PubMed ID: 27996999
[TBL] [Abstract][Full Text] [Related]
58. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
Tardy-Poncet B; Piot M; Montmartin A; Burdier A; Chalayer E; Tardy B
Thromb Haemost; 2015 Aug; 114(3):652-4. PubMed ID: 26062524
[No Abstract] [Full Text] [Related]
59. A 65-Year-Old Man with Bilateral Adrenal Hemorrhage Following Prophylaxis for Postoperative Deep Vein Thrombosis with Rivaroxaban.
Al-Rawi S; Seidahmed M; Emam SS; Othman ES
Am J Case Rep; 2023 Sep; 24():e939816. PubMed ID: 37658601
[TBL] [Abstract][Full Text] [Related]
60. Adrenal hemorrhage in patients with primary antiphospholipid syndrome: imaging findings.
Provenzale JM; Ortel TL; Nelson RC
AJR Am J Roentgenol; 1995 Aug; 165(2):361-4. PubMed ID: 7618557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
